Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 175

1.

Preparedness of healthcare workers at French Ebola referral centres.

Tarantini C, Peretti-Watel P, Yazdanpana Y, Guery B, Chidiac C, Rapp C, Brouqui P.

New Microbes New Infect. 2015 Feb 17;6:40-1. doi: 10.1016/j.nmni.2014.12.005. eCollection 2015 Jul. No abstract available.

2.

[Antimicrobial stewardship policy: Improve the quality of medical practices and not subject the infectious diseases specialists].

Roger PM, Leroy J, Garrait V, Guery B.

Med Mal Infect. 2016 Apr 7. pii: S0399-077X(16)00062-7. doi: 10.1016/j.medmal.2016.03.002. [Epub ahead of print] French. No abstract available.

PMID:
27068605
3.

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways.

Faure E, Bortolotti P, Kipnis E, Faure K, Guery B.

J Vis Exp. 2016 Jan 13;(107). doi: 10.3791/53218.

PMID:
26863066
4.

Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults.

Deconinck L, Flateau C, Pichenot M, Morell-Dubois S, Maillard H, Hatron PY, Guery B, Faure K.

Med Mal Infect. 2016 Mar;46(2):87-92. doi: 10.1016/j.medmal.2015.12.013. Epub 2016 Feb 2.

PMID:
26850899
5.

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, Scanzi J, Chast F, Batista R, Joly F, Joly AC, Collignon A, Guery B, Beaugerie L; French Group of Faecal microbiota Transplantation (FGFT), Alric L, Aucouturier JP, Amiot A, Barbut F, Batista R, Beaugerie L, Bemer P, Benamouzig R, Benech N, Billioud C, Boschetti G, Bourlioux P, Boubaddi N, Bouguen G, Bourreille A, Carbonnel F, Cesbron-Metivier E, Chast F, Coffin B, Collignon A, Collins M, Davido B, Davion T, Dinh A, Duboc H, Ducrotte P, Fraisse T, Gachot B, Galperine T, Guery B, Guillet M, Heyman B, Joly AC, Joly F, Kapel N, Metivier E, Mille F, Mosca A, Nebbad B, Perlemuter G, Piche T, Reimund JM, Revest M, Sabate JM, Scanzi J, Seksik P, Sobhani I, Sokol H, Schneider S, Trang C, Viennot S, Viala M, Voican C, Zerbib F.

Dig Liver Dis. 2016 Mar;48(3):242-7. doi: 10.1016/j.dld.2015.08.017. Epub 2015 Sep 7.

PMID:
26433619
6.

[European Antibiotic Awareness Day: What is new in France?].

Pulcini C, Alfandari S, Ballereau F, Bonnet E, Bruneel F, Castan B, Chidiac C, Cohen R, Descamps D, Doco-Lecompte T, Gauzit R, Guéry B, Jarlier V, Lesprit P, Marcelin AG, Molina JM, Rabaud C, Riché A, Salmon-Céron D, Senneville E, Stahl JP, Tattevin P, Varon E, Roblot F; conseil d’administration de la SPILF.

Med Mal Infect. 2015 Sep;45(9):345-7. doi: 10.1016/j.medmal.2015.08.001. Epub 2015 Sep 26. French. No abstract available.

PMID:
26411783
7.

Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia.

Thépaut M, Grandjean T, Hober D, Lobert PE, Bortolotti P, Faure K, Dessein R, Kipnis E, Guery B.

Vet Res. 2015 Sep 4;46:91. doi: 10.1186/s13567-015-0239-3.

8.

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.

Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O; French Mycosis Study Group.

J Antimicrob Chemother. 2015 Nov;70(11):3116-23. doi: 10.1093/jac/dkv236. Epub 2015 Aug 27.

PMID:
26316385
9.

Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes.

Anantharajah A, Buyck JM, Faure E, Glupczynski Y, Rodriguez-Villalobos H, De Vos D, Pirnay JP, Bilocq F, Guery B, Tulkens PM, Mingeot-Leclercq MP, Van Bambeke F.

Pathog Dis. 2015 Oct;73(7). pii: ftv049. doi: 10.1093/femspd/ftv049. Epub 2015 Jul 22.

PMID:
26203053
10.

Extensive Inflammatory Gingival Tumor in a Young Nonsmoking Woman: Back to Basics.

Hajji F, Beraud G, Genay A, Raoul G, Faure K, Guery B, Ferri J.

J Craniofac Surg. 2015 Jul;26(5):e388-90. doi: 10.1097/SCS.0000000000001865.

PMID:
26163848
11.

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP; Société de Réanimation de Langue Française (SRLF); Société Française d’Anesthésie et de Réanimation (SFAR).

Intensive Care Med. 2015 Jul;41(7):1181-96. doi: 10.1007/s00134-015-3853-7. Epub 2015 Jun 3.

PMID:
26077053
12.

Diguanylate cyclase DgcP is involved in plant and human Pseudomonas spp. infections.

Aragon IM, Pérez-Mendoza D, Moscoso JA, Faure E, Guery B, Gallegos MT, Filloux A, Ramos C.

Environ Microbiol. 2015 Nov;17(11):4332-51. doi: 10.1111/1462-2920.12856. Epub 2015 Apr 28.

PMID:
25809128
13.

Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry.

Alanio A, Garcia-Hermoso D, Mercier-Delarue S, Lanternier F, Gits-Muselli M, Menotti J, Denis B, Bergeron A, Legrand M, Lortholary O, Bretagne S; French Mycosis Study Group.

Clin Microbiol Infect. 2015 Jun;21(6):594.e1-5. doi: 10.1016/j.cmi.2015.01.017. Epub 2015 Jan 28.

PMID:
25726039
14.

Specific detection of type II human chorionic gonadotropin beta subunit produced by trophoblastic and neoplastic cells.

Aldaz-Carroll L, Richon S, Dangles-Marie V, Cocquebert M, Fournier T, Troalen F, Stevens D, Guery B, Hersant AM, Guibourdenche J, Nordor A, Pecking A, Bellet D.

Clin Chim Acta. 2015 Apr 15;444:92-100. doi: 10.1016/j.cca.2015.02.009. Epub 2015 Feb 12.

15.

Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.

Boukerb AM, Rousset A, Galanos N, Méar JB, Thépaut M, Grandjean T, Gillon E, Cecioni S, Abderrahmen C, Faure K, Redelberger D, Kipnis E, Dessein R, Havet S, Darblade B, Matthews SE, de Bentzmann S, Guéry B, Cournoyer B, Imberty A, Vidal S.

J Med Chem. 2014 Dec 26;57(24):10275-89. doi: 10.1021/jm500038p. Epub 2014 Dec 8.

PMID:
25419855
16.

Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases.

Poissy J, Goffard A, Parmentier-Decrucq E, Favory R, Kauv M, Kipnis E, Mathieu D, van der Werf S, Guery B; MERS-CoV Biology Group.

J Clin Virol. 2014 Oct;61(2):275-8. doi: 10.1016/j.jcv.2014.07.002. Epub 2014 Jul 12. Erratum in: J Clin Virol. 2015 Feb,63:94. van der Werf, S [added].

PMID:
25073585
17.

Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.

Genestet C, Le Gouellec A, Chaker H, Polack B, Guery B, Toussaint B, Stasia MJ.

Free Radic Biol Med. 2014 Aug;73:400-10. doi: 10.1016/j.freeradbiomed.2014.06.003. Epub 2014 Jun 12. Review.

PMID:
24929180
18.

Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.

Guéry B, Alberti C, Servais A, Harrami E, Bererhi L, Zins B, Touam M, Joly D.

PLoS One. 2014 May 13;9(5):e97187. doi: 10.1371/journal.pone.0097187. eCollection 2014.

19.

Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.

Faure E, Mear JB, Faure K, Normand S, Couturier-Maillard A, Grandjean T, Balloy V, Ryffel B, Dessein R, Chignard M, Uyttenhove C, Guery B, Gosset P, Chamaillard M, Kipnis E.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):799-811. doi: 10.1164/rccm.201307-1358OC.

PMID:
24555512
20.

Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, Bortolotti P, Martinez L, Dubucquoi S, Dessein R, Gosset P, Mathieu D, Guery B.

PLoS One. 2014 Feb 14;9(2):e88716. doi: 10.1371/journal.pone.0088716. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk